Evaluating chronic pain as a risk factor for COVID-19 complications among New York State Medicaid beneficiaries: a retrospective claims analysis.


Journal

Pain medicine (Malden, Mass.)
ISSN: 1526-4637
Titre abrégé: Pain Med
Pays: England
ID NLM: 100894201

Informations de publication

Date de publication:
01 Dec 2023
Historique:
received: 01 03 2023
revised: 10 08 2023
accepted: 28 08 2023
pmc-release: 31 08 2024
medline: 4 12 2023
pubmed: 31 8 2023
entrez: 31 8 2023
Statut: ppublish

Résumé

To assess whether chronic pain increases the risk of COVID-19 complications and whether opioid use disorder (OUD) differentiates this risk among New York State Medicaid beneficiaries. This was a retrospective cohort study of New York State Medicaid claims data. We evaluated Medicaid claims from March 2019 through December 2020 to determine whether chronic pain increased the risk of COVID-19 emergency department (ED) visits, hospitalizations, and complications and whether this relationship differed by OUD status. We included beneficiaries 18-64 years of age with 10 months of prior enrollment. Patients with chronic pain were propensity score-matched to those without chronic pain on demographics, utilization, and comorbidities to control for confounders and were stratified by OUD. Complementary log-log regressions estimated hazard ratios (HRs) of COVID-19 ED visits and hospitalizations; logistic regressions estimated odds ratios (ORs) of hospital complications and readmissions within 0-30, 31-60, and 61-90 days. Among 773 880 adults, chronic pain was associated with greater hazards of COVID-related ED visits (HR = 1.22 [95% CI: 1.16-1.29]) and hospitalizations (HR = 1.19 [95% CI: 1.12-1.27]). Patients with chronic pain and OUD had even greater hazards of hospitalization (HR = 1.25 [95% CI: 1.07-1.47]) and increased odds of hepatic- and cardiac-related events (OR = 1.74 [95% CI: 1.10-2.74]). Chronic pain increased the risk of COVID-19 ED visits and hospitalizations. Presence of OUD further increased the risk of COVID-19 hospitalizations and the odds of hepatic- and cardiac-related events. Results highlight intersecting risks among a vulnerable population and can inform tailored COVID-19 management.

Identifiants

pubmed: 37651585
pii: 7257075
doi: 10.1093/pm/pnad121
pmc: PMC10690846
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1296-1305

Subventions

Organisme : NIDA NIH HHS
ID : T32 DA031099
Pays : United States
Organisme : NIH HHS
ID : R01DA045872-01A1S2
Pays : United States

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

PLoS One. 2022 Nov 2;17(11):e0275095
pubmed: 36322526
Subst Abuse Treat Prev Policy. 2018 Jun 1;13(1):22
pubmed: 29859110
Br J Ophthalmol. 2021 Mar;105(3):306-310
pubmed: 32532764
J R Soc Med. 2021 Sep;114(9):428-442
pubmed: 34265229
BMC Musculoskelet Disord. 2020 Jan 16;21(1):36
pubmed: 31948483
JAMA Netw Open. 2021 Nov 1;4(11):e2134147
pubmed: 34762110
Cardiol Rev. 2015 Nov-Dec;23(6):303-11
pubmed: 25580707
Eur Respir J. 2020 Aug 13;56(2):
pubmed: 32817205
Prev Chronic Dis. 2021 Feb 18;18:E13
pubmed: 33600305
Postgrad Med J. 2021 Feb;97(1144):110-116
pubmed: 32788312
Pain. 2023 Jan 1;164(1):84-90
pubmed: 35452027
Best Pract Res Clin Anaesthesiol. 2020 Sep;34(3):529-537
pubmed: 33004164
Pain Med. 2009 Mar;10(2):289-99
pubmed: 19207233
Pain Manag. 2012 May;2(3):219-230
pubmed: 23687518
J Pain. 2019 Jul;20(7):796-809
pubmed: 30658177
Rheumatology (Oxford). 2022 Jun 28;61(SI2):SI189-SI190
pubmed: 35253865
Curr Pain Headache Rep. 2022 May;26(5):379-383
pubmed: 35267156
Can J Pain. 2020 Jun 8;4(1):125-128
pubmed: 33987492
Anesthesiology. 2014 Oct;121(4):675-7
pubmed: 25099749
Pain. 2022 Feb 1;163(2):e328-e332
pubmed: 33990113
J Pain. 2019 Dec;20(12):1429-1445
pubmed: 31129316
Med Care. 2016 May;54(5):435-41
pubmed: 26807540
Pain Med. 2021 Feb 23;22(2):470-480
pubmed: 33537764
Rheumatology (Oxford). 2021 Mar 2;60(3):1091-1105
pubmed: 33276382
BMC Health Serv Res. 2021 May 24;21(1):494
pubmed: 34030684
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
Exp Clin Psychopharmacol. 2008 Oct;16(5):405-16
pubmed: 18837637
J Am Med Inform Assoc. 2013 Dec;20(e2):e275-80
pubmed: 23904323
Adv Exp Med Biol. 2003;521:117-25
pubmed: 12617570
Drug Alcohol Depend. 2010 Nov 1;112(1-2):90-8
pubmed: 20634006
Ann Intern Med. 2020 Jul 7;173(1):61-62
pubmed: 32240293
Pain Med. 2014 May;15(5):772-81
pubmed: 24612225
Mol Psychiatry. 2021 Jan;26(1):40
pubmed: 32999436
SN Compr Clin Med. 2020;2(7):874-876
pubmed: 32838138
J Infect Public Health. 2020 Dec;13(12):1833-1839
pubmed: 32788073
BMJ. 2021 Mar 10;372:n436
pubmed: 33692022
Biometrics. 1978 Mar;34(1):57-67
pubmed: 630037
J Rehabil Res Dev. 2016;53(1):37-44
pubmed: 27005596
EClinicalMedicine. 2022 Jan;43:101230
pubmed: 34927038
F1000Res. 2016 Sep 30;5:
pubmed: 27781082
J Pain Res. 2017 Feb 08;10:327-339
pubmed: 28223842
World Psychiatry. 2022 Feb;21(1):124-132
pubmed: 34612005

Auteurs

Allison Perry (A)

Center for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine, New York, NY 10016, United States.

Katherine Wheeler-Martin (K)

Center for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine, New York, NY 10016, United States.

Kelly Terlizzi (K)

Department of Population Health, NYU Grossman School of Medicine, New York, NY 10016, United States.

Noa Krawczyk (N)

Center for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine, New York, NY 10016, United States.

Victoria Jent (V)

Center for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine, New York, NY 10016, United States.

Deborah S Hasin (DS)

Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY 10032, United States.

Charles Neighbors (C)

Department of Population Health, NYU Grossman School of Medicine, New York, NY 10016, United States.

Zachary L Mannes (ZL)

Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY 10032, United States.

Lisa V Doan (LV)

Department of Anesthesiology, Perioperative Care and Pain Medicine, New York University Grossman School of Medicine, New York, NY 10016, United States.

John R Pamplin Ii (JR)

Center for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine, New York, NY 10016, United States.
Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY 10032, United States.

Tarlise N Townsend (TN)

Center for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine, New York, NY 10016, United States.

Stephen Crystal (S)

Center for Health Services Research, Rutgers Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ 08901, United States.

Silvia S Martins (SS)

Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY 10032, United States.

Magdalena Cerdá (M)

Center for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine, New York, NY 10016, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH